BR100 Increased By (1.06%)
BR30 Increased By (1.64%)
KSE100 Increased By (0.71%)
KSE30 Increased By (0.78%)
BECO 6.08 Increased By ▲ 0.31 (5.37%)
BML 53.29 Increased By ▲ 0.29 (0.55%)
BOP 34.38 Increased By ▲ 0.39 (1.15%)
CNERGY 8.15 Increased By ▲ 0.04 (0.49%)
DCL 12.24 Increased By ▲ 0.04 (0.33%)
FCCL 54.01 Increased By ▲ 1.18 (2.23%)
FCSC 5.19 Increased By ▲ 0.12 (2.37%)
FFL 18.15 Increased By ▲ 0.20 (1.11%)
FNEL 1.32 Increased By ▲ 0.03 (2.33%)
HUMNL 11.05 Increased By ▲ 0.17 (1.56%)
KEL 8.15 Increased By ▲ 0.13 (1.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 88.25 Increased By ▲ 1.74 (2.01%)
NBP 187.50 Increased By ▲ 2.34 (1.26%)
PACE 10.67 Increased By ▲ 0.09 (0.85%)
PAEL 39.97 Increased By ▲ 0.55 (1.4%)
PIAHCLA 26.18 Decreased By ▼ -0.04 (-0.15%)
PIBTL 17.38 Increased By ▲ 0.71 (4.26%)
PPL 232.63 Increased By ▲ 4.45 (1.95%)
PRL 35.05 Increased By ▲ 0.37 (1.07%)
PTC 67.35 Increased By ▲ 2.02 (3.09%)
SEARL 91.03 Increased By ▲ 0.90 (1%)
SSGC 27.10 Increased By ▲ 0.50 (1.88%)
TELE 8.66 Increased By ▲ 0.38 (4.59%)
THCCL 59.66 Increased By ▲ 1.16 (1.98%)
TPLP 8.82 Increased By ▲ 0.60 (7.3%)
TREET 24.60 Increased By ▲ 0.07 (0.29%)
TRG 71.25 Increased By ▲ 1.54 (2.21%)
WAVES 10.00 Increased By ▲ 0.06 (0.6%)
WTL 1.26 Decreased By ▼ -0.02 (-1.56%)
By

NEW YORK: Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday. The new price for the Pfizer shot was 19.50 euros ($23.15) against 15.50 euros previously, the newspaper said, citing portions of the contracts seen.

The price of a Moderna vaccine was $25.50 a dose, the contracts show, up from about 19 euros in the first procurement deal but lower than the previously agreed $28.50 because the order had grown, the report said, citing one official close to the matter.

The European Commission said on Tuesday that the EU is on course to hit a target of fully vaccinating at least 70% of the adult population by the end of the summer.

In May, the EU said it expects to have received more than a billion doses of vaccines by the end of September from four drugmakers. Pfizer and Moderna were not immediately available for comment to Reuters.

Comments

Comments are closed for this article.